首页/数据集/GRADE evidence profile: Sarcopenia vs. non-sarcopenia for OS in rectal cancer patients.

GRADE evidence profile: Sarcopenia vs. non-sarcopenia for OS in rectal cancer patients.

NIAID Data Ecosystem2026-03-13 收录

数据链接：

https://figshare.com/articles/dataset/GRADE_evidence_profile_Sarcopenia_vs_non-sarcopenia_for_OS_in_rectal_cancer_patients_/20147871 数据链接链接失效反馈

官方服务：

资源简介：

GRADE evidence profile: Sarcopenia vs. non-sarcopenia for OS in rectal cancer patients.

应用场景：

创建时间：

2022-06-24

生物标志物发现

结直肠癌预后评估

Proteomics and Phosphoproteomics Profiling of PGCCs Reveal AARS as a Prognostic Biomarker for Colorectal Cancer

integrated proteome resources80

Survival Benefits of Metformin for Colorectal Cancer Patients with Diabetes: A Systematic Review and Meta-Analysis

结直肠癌预后评估

药物流行病学

BackgroundSeveral studies suggest that metformin has the potential effect of reducing cancer risk. However, its survival benefit in patients with colorectal cancer (CRC) and diabetes is unknown. The a

Figshare2016-01-18 更新40

结直肠癌预后评估

肿瘤浸润淋巴细胞

The densities of CD3 + and CD8 + tumor-infiltrating lymphocytes (TILs), combined with tumor-node-metastasis (TNM) staging, have prognostic value for patients with nonmetastatic col

Zenodo2020-08-01 更新20

结直肠癌预后评估

肿瘤免疫微环境分析

The densities of CD3+ and CD8+ tumor-infiltrating lymphocytes (TILs), combined with tumor-node-metastasis (TNM) staging, have prognostic value for patients with nonmetastatic colorectal cancer. We com

NIAID Data Ecosystem60

Supplementary Material for: High Expression of MMP-9 in Primary Tumors and High Preoperative MPO in Serum Predict Improved Prognosis in Colorectal Cancer with Operable Liver Metastases

结直肠癌预后评估

肿瘤生物标志物

Introduction: The liver metastases of colorectal cancer (CRC) can be surgically treated in selected cases, with continuously improving results. Matrix metalloproteinases (MMPs) contribute to cancer in

NIAID Data Ecosystem30

GRADE evidence profile: Sarcopenia vs. non-sarcopenia for OS in rectal cancer patients.

资源简介：

相关数据集